MICRONOR Drug Patent Profile
✉ Email this page to a colleague
When do Micronor patents expire, and when can generic versions of Micronor launch?
Micronor is a drug marketed by Janssen Pharms and is included in one NDA.
The generic ingredient in MICRONOR is norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the norethindrone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Micronor
A generic version of MICRONOR was approved as norethindrone by GLENMARK GENERICS on July 22nd, 2010.
Summary for MICRONOR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 76 |
Clinical Trials: | 2 |
Patent Applications: | 3,780 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in MICRONOR? | MICRONOR excipients list |
DailyMed Link: | MICRONOR at DailyMed |
Recent Clinical Trials for MICRONOR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of California, San Diego | Phase 4 |
University of Southern California | Phase 3 |
Society of Family Planning | Phase 3 |
US Patents and Regulatory Information for MICRONOR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Janssen Pharms | MICRONOR | norethindrone | TABLET;ORAL-28 | 016954-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |